Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study
JAAD International
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S2666328726001446?dgcid=rss_sd_all
Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study. JAAD International. https://www.sciencedirect.com/science/article/pii/S2666328726001446?dgcid=rss_sd_all
“Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study.” JAAD International.
@article{article50655,
title = {Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S2666328726001446?dgcid=rss_sd_all}
}